1st January 2023 Resubmission filed $0.908th March 2023...

1st January 2023 Resubmission filed $0.90
8th March 2023 Resubmission accepted. PFUFA 01/08/2023------------- 5 months $0.95
26th May 2023- company advises manufacturing plant has passed inspection $1.08
14th July 2023 price peak during resubmission process $1.39

Calls for $6.50 are way off imo.

Prior price from resubmission acceptance to peak price was 46%

Current market cap $1.23 billion

add 50% to $1.84 billion or $1.64 per share

If we get an approval then the product pipeline comes into play, with AA Heart meeting potentially in the same quarter.

Quarterly update due January 31st 2025 will be the first key indicator of sales.

Then we can look at $6.50 plus

But if heart AA gets up, then triple it - we have either partnered or been swallowed.



Nice to dream , nice upside, had enough of the down side.

Major shareholder bought 50,000,000 shares as soon as the FDA said to refile the BLA

I added a few myself


Reg


All above pure speculation, you do you